GT Biopharma GTBP
NASDAQ GTBP
$0.28 -0.01 (-3.45%)
At close: Aug 20, 2026 · 4:00 PM EDT

GT Biopharma (GTBP) Operating Leases (2022 - 2024)

GT Biopharma (GTBP) posted quarterly Operating Leases of $30000.0 for Q1 2024, down 3.23% year-over-year from $31000.0 in Q2 2023, and down 99.95% quarter-over-quarter from $58.0 million in Q4 2023.

GT Biopharma (GTBP) Operating Leases (2022 - 2024) Analysis & Trends

GT Biopharma (GTBP) has reported Operating Leases for 3 consecutive years, with $30000.0 the latest figure, recorded in Q1 2024.

  • In Q1 2024, Operating Leases fell 3.23% year-over-year to $30000.0; the TTM figure through Mar 2024 stood at $30000.0 (down 3.23% YoY), while the FY2023 annual figure was $58.0 million, up 90525.0% from the prior year.
  • Operating Leases eased to $30000.0 in Q1 2024 per GTBP's latest filing, from $58.0 million in the prior quarter.
  • Across five years, Operating Leases topped out at $58.0 million in Q4 2023 and bottomed at $30000.0 in Q1 2024.
  • Historically, Operating Leases has averaged $8.4 million across 3 years, with a median of $92000.0 in 2022.
  • On a YoY basis, Operating Leases climbed as much as 90525.0% in 2023 and fell as far as 78.91% in 2023.
  • GT Biopharma's Operating Leases stood at $64000.0 in 2022, then soared by 90525.0% to $58.0 million in 2023, then plunged by 99.95% to $30000.0 in 2024.
  • Business Quant data shows GTBP's Operating Leases at $30000.0 in Q1 2024, $58.0 million in Q4 2023, and $31000.0 in Q1 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn
8 Royalty Pharma 26.98 Bn 26.14 Bn -
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn
10 GT Biopharma 8.38 Mn 8.38 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2024 30,000.00
Dec 31, 2023 58.00 Mn
Mar 31, 2023 31,000.00
Dec 31, 2022 64,000.00
Sep 30, 2022 92,000.00
Jun 30, 2022 120,000.00
Mar 31, 2022 147,000.00